Protagonist Announces Positive Topline Results From Phase 3 ICONIC[...]
Protagonist Therapeutics to Host Conference Call to Announce an Oral[...]
Protagonist Announces Nomination of PN 881, a Potential Best in Class[...]
11/06/2024 | Press release | Distributed by Public on 11/06/2024 08:02
Please select the service you want to use:
Smartlinks | Jacobs Solutions Inc. | News | Local News | Finance | Security Markets | Security Markets | Company News | Top Company News | Corporate Debt | Construction and Engineering | Construction and Engineering Companies | Securities Issuers | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Frankfurt Stock Exchange | Sao Paulo Stock Exchange (B3) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Stuttgart Stock Exchange | Bolsa Mexicana de Valores (BMV) | BX Swiss | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Cboe BZX Exchange | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | Bolsa Institucional de Valores (BIVA) | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact